| Product Information |
|
| Registration Number |
DR-XY47870
|
| Generic Name |
Acalabrutinib
|
| Brand Name |
Calquence
|
| Dosage Strength |
100 mg
|
| Dosage Form |
Capsule
|
| Classification |
Prescription Drug (Rx)
|
| Pharmacologic Category |
Antineoplastic agent (Protein Kinase Inhibitor)
|
| Packaging |
Alu/Alu Blister Pack x 8's (Box of 56's)
|
| Manufacturer |
AstraZeneca AB
|
| Country of Origin |
Sweden
|
| Trader |
|
| Importer |
AstraZeneca AB
|
| Distributor |
AstraZenecaPharmaceuticals (Phils.), Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
30 March 2022
|
| Expiry Date |
30 March 2027
|